Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
Magnus Gisslén(Public Health Agency of Sweden), Henrik Zetterberg(University of Wisconsin–Madison), Bruce J. Brew(UNSW Sydney), Kaj Blennow(Sahlgrenska University Hospital), Ulf Andréasson(Sahlgrenska University Hospital), Jan Jessen Krut(University of Gothenburg), Richard W. Price(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Serena Spudich(Yale University), Lars Hagberg(Sahlgrenska University Hospital), Paola Cinque(University of California San Diego), Lars Rosengren(Sahlgrenska University Hospital)
Cited by 149
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k